Syk (p72
) is a 72-kDa cytoplasmic protein-tyrosine kinase that is expressed in a variety of hematopoietic cells where it participates in signal transduction cascades initiated by the engagement of the cell surface receptors with which it associates. Syk is activated in B lymphocytes by aggregation of the B-cell antigen receptor (BCR) 1 (1); in platelets by thrombin (2) or by integrin ligation (3); in mast cells by aggregation of Fc⑀RI receptors (4) ; in monocytes by cross-linking Fc␥RI and Fc␥RII receptors (5, 6) ; in macrophages by engagement of the Fc␥RIIIA receptor (7); in T-cells by cross-linking the T-cell antigen receptor (TCR) (8, 9) ; in peripheral blood lymphocytes by interleukin-2 (10); and in granulocytes in response to granulocyte colony-stimulating factor (11) .
The activation of Syk in response to the engagement of multichain immune recognition receptors (12) has been studied in the greatest detail. The aggregation of these receptors leads to the phosphorylation of multiple cellular proteins on tyrosine, initiating signaling cascades resulting in increased inositol 1,4,5-trisphosphate production and calcium mobilization (for reviews, see Refs. [13] [14] [15] [16] . That Syk is an important mediator of receptor signaling is indicated by an absence of signaling in Syk Ϫ DT40 chicken B-cells (17) , an inhibition of Fc⑀RI-mediated signaling in mast cells by a Syk-selective inhibitor (18) , and a blockage in B-cell development in Syk Ϫ "knockout" mice at stages that normally require signals to be sent through the BCR or pre-BCR (19) .
The efficient activation of Syk requires the presence on receptor components of an immunoreceptor tyrosine activation motif (ITAM), consisting of two YXXL/I cassettes separated by 6 -8 amino acids (20) and the presence of at least one member of the Src family of protein-tyrosine kinases. Receptor aggregation leads to the rapid phosphorylation of the ITAM, presumably by Src family kinases, establishing a binding site for the two tandem, amino-terminal, SH2 domains of Syk. This occupancy allows the kinase to catalyze an autophosphorylation reaction, which leads to an increase in its intrinsic activity (21) .
Many of the proteins phosphorylated in response to receptor aggregation are likely to be substrates for Syk or for Sykactivated kinases. However, little is known regarding the nature of the substrates that are phosphorylated by activated Syk and where in the cell these protein-substrate interactions occur. Whether these interactions occur while Syk is associated with the receptor, for example, has not been explored in detail.
To begin examining such questions, we have used cellular fractionation techniques to characterize the cytosolic and membrane-associated pools of Syk. In this report, we show that Syk activated by the aggregation of the BCR is found almost exclusively in the cytosolic fraction of activated B-cells. This activated, cytosolic Syk associates with and phosphorylates tubulin. In vitro, ␣-tubulin is an excellent substrate for Syk and becomes phosphorylated on a tyrosine residue located near the carboxyl terminus.
MATERIALS AND METHODS
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consisting of glutathione S-transferase (GST) linked to the carboxylterminal 35-kDa kinase domain of murine Syk (GST-p35). Antibodies to phosphotyrosine (1) and ␤-tubulin (23) were prepared as described previously. Anti-ZAP-70 antibodies were generously provided by Dr. Lawrence Samelson, NIH. Tubulin was purified from chick brain by a reversible assembly method followed by chromatography on phosphocellulose as described elsewhere (24) . Myelin basic protein was a gift of Dr. Curt Ashendel, Purdue University, and the cytoplasmic fragment of human erythrocyte band 3 (cfb3) was obtained from Dr. Philip Low, Purdue University. Piceatannol was described previously (18) .
Preparation of GST-Syk Fusion Proteins-The cloning of murine Syk cDNA and the expression of full-length Syk in Sf9 cells will be described elsewhere. 2 To prepare a GST-Syk fusion protein, an XhoI site was introduced by site-directed mutagenesis (25) into the Syk cDNA 15 bp upstream from the translational start site. A 3-kilobase pair XhoI/XbaI fragment containing full-length Syk cDNA was then subcloned into the XhoI/XbaI site of the baculoviral transfer vector pNTX (a gift of Dr. Harry Charbonneau, Purdue University). This vector is designed, when introduced into Sf9 cells, to direct the expression of cDNA inserts as GST fusion proteins. Sf9 cells were co-transfected with this plasmid (pNTXSyk) and BacPAK 6 viral DNA (Clontech), and plaque purification was carried out essentially as described previously (26) . Recombinant plaques were used to infect Sf9 cells, which were screened 48 h postinfection for enzymatically active GST-Syk. GST-Syk was isolated from Sf9 cell lysates by adsorption to glutathione-Sepharose.
To prepare GST-p35, the GST-Syk-expressing transfer vector pNTXSyk was digested with XhoI (just upstream of the translational start site) and ApaI (codon for proline 326). The vector fragment was gelpurified, blunt-ended with mung bean nuclease, and recircularized to generate pNTXp35. Sequencing of the fusion junction confirmed that the open reading frame had been maintained. Sf9 cell co-transfection and plaque purification were carried out as described above for GST-Syk.
Cells and Cellular Fractionation-Murine Bal17 and human DG75 B lymphocytes (5-10 ϫ 10 6 cells/sample) were incubated on ice in the presence or absence of affinity-purified anti-IgM F(abЈ) 2 fragments of goat anti-mouse IgM (Cappel) at a concentration of 25 g/ml or goat anti-human IgM antibodies (Zymed) at 37.5 g/ml, respectively, for the times indicated. Cells were then suspended in 800 l of 5 mM Hepes, pH 7.5, 1 mM MgCl 2 , 1 mM sodium orthovanadate, 10 g/ml aprotinin, 10 g/ml leupeptin and lysed by 100 strokes of a Dounce homogenizer. Nuclei and unbroken cells were removed by centrifugation at 644 ϫ g for 5 min at 4°C. Soluble and particulate fractions were obtained by ultracentrifugation of the cleared lysate at 150,000 ϫ g for 30 min at 4°C. Pellets were resuspended in the above buffer containing 1% Triton X-100 and 150 mM NaCl. The supernatant was also adjusted to a final concentration of 1% Triton X-100 and 150 mM NaCl. In some experiments, cells were pretreated with Taxol (7.5 g/ml) for 2.5 h prior to addition of the activating antibody. For these experiments, control cells were incubated with 0.75% Me 2 SO, which serves also as the carrier for Taxol. In other experiments, Bal17 B-cells or Jurkat T-cells were pretreated with pervanadate formed by mixing sodium orthovanadate (0.1 mM) with H 2 O 2 (1 mM).
Immunoprecipitations and Immune Complex Kinase Assays-Proteins were immunoprecipitated from soluble and particulate fractions using anti-Syk or anti-phosphotyrosine antibodies coupled to protein A-Sepharose as described previously (22) . Procedures for the detection of kinases and substrates present in immune complexes by incubation with [␥-32 P]ATP, fractionation by SDS-PAGE, and transfer to poly(vinylidene fluoride) membranes (Immobilon P) have been described in detail (22) . Phosphotyrosine-containing proteins were detected by autoradiography of poly(vinylidene fluoride) membranes that had been treated with 1 N KOH at 55°C for 2 h to reduce the levels of phosphoserine and phosphothreonine.
For some experiments, GST-Syk immobilized on glutathione-Sepharose (see above) was used in place of the antibody-protein A-Sepharose complex.
Chromatography on Colchicine-Sepharose-Colchicine-Sepharose was prepared as described by Schmitt and Littauer (27) . Lysates were prepared by Dounce homogenization of anti-IgM-activated or untreated cells as described above except the lysis buffer contained 10 mM imidazole, pH 6.8, 5 mM MgCl 2 , 1 mM sodium orthovanadate, and 10 g/ml each of aprotinin and leupeptin. In some experiments, cells were pretreated for 1 h with piceatannol (15 g/ml) prior to activation. Lysates from 1 ϫ 10 7 cells were incubated with 60 nmol immobilized colchicine for 1 h at 4°C. The resin was washed 3 times with lysis buffer. Bound proteins were eluted with 1% SDS, separated by SDS-PAGE, transferred to Immobilon P membranes, and probed using antibodies against phosphotyrosine or ␤-tubulin. Immunoreactive proteins were detected using the enhanced chemiluminescence (ECL) method of Amersham Corp. Substrate Phosphorylation-In vitro kinase reactions for recombinant Syk contained 1 M protein substrate (tubulin dimer, cfb3, or myelin basic protein), 25 mM Hepes, pH 7.5, 1 mM sodium orthovanadate, 10 g/ml bovine serum albumin, 2 mM MnCl 2 , 10 M ATP, and 25 Ci of [␥-
32 P]ATP. Reactions were carried out at 30°C for the times indicated and terminated by the addition of SDS sample buffer. Phosphoproteins were separated by SDS-PAGE, detected by autoradiography, and excised from the gels. The extent of phosphorylation was quantified by liquid scintillation spectrometry. For some separations, electrophoresis conditions were altered to allow separation of ␣-and ␤-tubulin monomers (28) .
Proteolysis of Phosphotubulin-Purified tubulin (3 g) was phosphorylated in vitro with GST-Syk immobilized on glutathione-Sepharose for 1 min at 30°C using the kinase reaction mixture described above. The reaction was terminated by the addition of 5 mM EDTA, and 3.7 ng of subtilisin was added and allowed to incubate for the times indicated. Alternatively, the kinase reaction was terminated by the removal of the immobilized GST-Syk by centrifugation and 0.03 g of carboxypeptidase A was added and incubated for the indicated times. Cleavage products were separated by SDS-PAGE. Proteins were visualized by staining with Coomassie Brilliant Blue, and phosphoproteins were detected by autoradiography.
One-dimensional peptide mapping of phosphoproteins was performed essentially as described by Cleveland et al. (29) . Phosphopeptides excised from SDS-polyacrylamide gels were reelectrophoresed on a 15% gel in the presence of 17 ng of Staphylococcus aureus V8 protease.
RESULTS

Syk Activity in the Cytosol Increases with BCR Stimulation-
Aggregation of the BCR leads to an increase in the intrinsic activity of Syk, which can be detected as an increase in the rate of Syk autophosphorylation in anti-Syk immune complexes (1, 30) . To examine the location of activated Syk, Syk was immunoprecipitated with anti-Syk peptide antibodies from the postnuclear particulate and cytosolic fractions of human DG75 B-cells that had been pretreated with anti-IgM antibodies for varying periods of time prior to Dounce homogenization. The resulting immune complexes were incubated in buffer containing [␥-32 P]ATP. As shown in Fig. 1A , receptor cross-linking resulted in only a modest increase in the intrinsic autophosphorylating activity of membrane-associated Syk (Fig. 1A) . A substantial increase in Syk activity was observed in the cytosolic fractions prepared from anti-IgM-activated cells as compared to control cells (Fig. 1A) . Active, soluble Syk could be detected in DG75 cells within 2 min (data not shown) and in Bal17 cells within 15 s (see Fig. 4A ) of receptor aggregation. Syk phosphorylated in immune complexes isolated from the cytosol of activated DG75 cells, but not from the particulate fraction, migrated on SDS-polyacrylamide gels as a closely spaced doublet.
Syk protein present in the anti-Syk peptide immune complexes was detected by Western blotting with anti-GST-p35 antibodies following the separation of the antigen-antibody complexes by SDS-PAGE (Fig. 1B) . The cross-linking of surface IgM had no appreciable effect on the amount of Syk recovered from either the particulate or soluble fractions.
Tyrosine-phosphorylated Syk Appears Solely in the Cytosolic Fraction of Anti-IgM-activated Cells-Aggregation of the BCR leads to an increase in the phosphotyrosine content of Syk (1, 30, 31) . To examine the location of tyrosine-phosphorylated Syk, phosphotyrosine-containing proteins were immunoprecipitated with anti-phosphotyrosine antibodies from particulate and soluble fractions prepared from DG75 B-cells activated for varying periods of time with anti-IgM antibodies. As shown in Fig. 2A , the vast majority of the Syk autophosphorylating activity was recovered from the cytosolic fraction of activated cells. Very little tyrosine phosphorylated Syk was recovered from the particulate fraction. The identity of the cytosolic, tyrosine-phosphorylated protein as Syk was verified by Western blot analysis of anti-phosphotyrosine immune complexes using anti-GST-p35 antibodies (Fig. 2B) .
The Syk protein recovered from the cytosolic fraction by immunoprecipitation with anti-phosphotyrosine antibodies and detected either by autophosphorylation ( Fig. 2A) or Western blotting (Fig. 2B ) migrated on SDS-PAGE as a single, prominent band and co-migrated with the upper band of the doublet observed in anti-Syk immune complex kinases assays (Fig. 1A) .
To determine if cytosolic Syk was also activated in murine B-cells, anti-Syk immune complexes were prepared from the particulate and soluble fractions of untreated or anti-IgM-activated Bal17 cells and incubated with buffer containing [␥-32 P]ATP. As shown in Fig. 3A , only the activity of Syk recovered from the cytosolic fraction was markedly affected by receptor cross-linking. The Ig-␣ component of the murine BCR, which migrates on SDS-polyacrylamide gels with an apparent molecular weight of 34,000, could be observed co-immunoprecipitating with Syk only in samples prepared from the particulate fraction (Fig. 3A) . (32) or pervanadate (33, 34) , leads to the tyrosine phosphorylation and activation of Syk, presumably by inhibiting the activities of phosphotyrosine phosphatases. To determine if pervanadate-stimulated Syk also appeared in the cytosolic fraction, anti-Syk immune complexes were prepared from the particulate or cytosolic fractions of untreated or pervanadate-treated Bal17 B-cells and incubated with [␥-32 P]ATP. As shown in Fig. 3B , addition of pervanadate primarily affected the activity of Syk recovered from the cytosolic fraction. Cytosolic Syk was also activated in Jurkat T-cells following treatment with pervanadate, as shown in Fig. 3C . The activity of ZAP-70, which is a Syk-related kinase expressed predominantly in T-cells, was also increased dramatically in the cytosolic fraction of pervanadate-treated Jurkat T-cells (Fig. 3C) .
Activation of Syk Kinases by Pervanadate in B-and T-cells-
Association of Syk with a 54-kDa Substrate-A 54-kDa protein co-immunoprecipitated with Syk from the cytosolic fractions of B-cells and became phosphorylated during immune complex kinase assays (Figs. 1A and 3A) , suggesting that this protein might represent a Syk-associated substrate. In murine Bal17 B-cells, this protein appeared in anti-Syk immune complexes shortly following receptor cross-linking and then decreased as a function of time (Fig. 4A) . To further explore the possibility that this was a Syk-associated protein, particulate and cytosolic extracts of anti-IgM-activated or unactivated cells were incubated with a glutathione-Sepharose resin containing bound GST-Syk. After washing, the resin was incubated with [␥- 32 P]ATP to identify Syk-associated substrates, which were detected by autoradiography following separation by SDS-PAGE. As shown in Fig. 4B , a major radiolabeled protein of 54 kDa was observed in the cytosolic extracts. This protein comigrated on SDS-polyacrylamide gels with the 54-kDa phosphoprotein detected in the anti-Syk immune complexes.
Identification of the 54-kDa Syk Substrate as TubulinBased on the apparent molecular weight of the Syk-associated substrate and recent reports of the tyrosine-phosphorylation of tubulin in human Jurkat T-cells (35), we examined the possi- 5 and 7-10 ) or with preimmune serum (P), (lanes 1 and 6) . The resulting immune complexes were incubated with [␥- bility that the 54-kDa phosphoprotein was, in fact, tubulin. To determine if tubulin was a substrate for Syk, purified chick brain tubulin was incubated with recombinant Syk in an in vitro kinase assay. As shown in Fig. 5A , tubulin was readily phosphorylated by Syk. Phosphoamino acid analysis identified the phosphorylated amino acid in tubulin as phosphotyrosine (data not shown). Purified tubulin alone contained no endogenous kinase activity and the preparation of recombinant Syk was devoid of phosphoproteins of 54 kDa.
Tubulin phosphorylated in vitro by Syk co-migrated by SDS-PAGE with the 54-kDa Syk-associated substrate (Fig. 5A) . Phosphopeptide mapping by partial proteolysis (29) of each protein gave rise to a single, prominent phosphopeptide that co-migrated on 15% SDS-polyacrylamide gels (Fig. 5B) , suggesting that they represented the same or highly related proteins.
To support the identification of the 54-kDa substrate as tubulin, we examined the effect of Taxol on its recovery from cytosolic fractions of activated Bal17 B-cells. Taxol stabilizes microtubules and promotes the polymerization of unassembled tubulin (36 -38) . Syk was immunoprecipitated with anti-Syk antibodies from the cytosolic fractions of anti-IgM-activated and unactivated Bal17 cells or Taxol-pretreated Bal17 cells and detected by autophosphorylation. As shown in Fig. 5C , the 54-kDa protein co-immunoprecipitated with Syk from the cytosolic fraction of anti-IgM-activated Bal17 cells, but not from activated cells that had been pretreated with Taxol. Phosphorylation of ␣-Tubulin by Syk in Vitro-Syk exhibits a very restricted substrate specificity in vitro. Therefore, we examined the ability of recombinant Syk to phosphorylate tubulin as compared to cfb3, an excellent Syk substrate (34, 39, 40) , and myelin basic protein, another substrate sometimes used to detect Syk activity (41, 42) . Equimolar amounts of tubulin dimer, cfb3, and myelin basic protein were phosphorylated in identical in vitro kinase reactions. The results, illustrated in Fig. 6 , A and B, indicate that tubulin, like cfb3, is an excellent substrate for Syk. In contrast, myelin basic protein is only poorly recognized as a substrate.
Tubulin exists as a heterodimer of tightly associated ␣ and ␤ subunits that exhibit about 40% sequence similarity (43) . To further examine the substrate specificity of Syk, phosphotubulin was separated by SDS-PAGE under conditions that allow separation of the distinct ␣ and ␤ subunits (28) . As shown in Fig. 7A , Syk selectively catalyzed the phosphorylation of the ␣-tubulin subunit.
Cleavage of ␣-and ␤-tubulin with subtilisin generates 50,000-kDa intermediates that lack the acidic carboxyl termini (44) . To explore the location of the site of phosphorylation on ␣-tubulin, purified tubulin was phosphorylated in vitro with recombinant GST-Syk and then incubated with subtilisin for varying periods of time. As illustrated in Fig. 7C , no radiolabel was associated with the 50-kDa fragments of ␣-and ␤-tubulin generated by digestion with subtilisin.
The 4-kDa carboxyl-terminal region of ␣-tubulin contains two potential sites of tyrosine phosphorylation, one internal site and a second at the extreme carboxyl terminus. To differentiate between these possible sites, tubulin phosphorylated in vitro by recombinant GST-Syk was incubated with carboxypeptidase A for varying periods of time. As shown in Fig. 7B , while carboxypeptidase A digestion generated slightly faster migrating forms of phosphotubulin, it did not rapidly catalyze removal of the radiolabeled amino acid (Fig. 7B) . This indicates that the principal site of phosphorylation on ␣-tubulin is not at the extreme carboxyl terminus.
Phosphorylation of Tubulin by BCR Cross-linking-To determine if tubulin was phosphorylated in anti-IgM-activated cells under conditions in which Syk was activated, cytosolic extracts of anti-IgM-activated Bal17 B-cells were adsorbed to colchicine-Sepharose and immunoblotted with anti-␤-tubulin and anti-phosphotyrosine antibodies. As shown in Fig. 8 , much of the tubulin present in cytosolic extracts was adsorbed to the colchicine resin (Panel B). Tubulin was rapidly and transiently phosphorylated on tyrosine following receptor cross-linking (Panel A).
Similar results were observed using the human DG75 Bcells. In this experiment, the ␣ and ␤ monomers were separated during electrophoresis. Receptor cross-linking primarily led to increases in the phosphorylation of the ␣ subunit.
To further establish a role for Syk in the phosphorylation of tubulin in intact cells, we examined the ability of piceatannol to block anti-IgM-stimulated tubulin phosphorylation. At low concentrations, piceatannol selectively inhibits the receptor-mediated activation of Syk as compared to the Src family kinases in mast cells (18) and B-cells. concentration, 0.15%) prior to activation with anti-IgM antibodies. As shown in Fig. 8D , the time-dependent phosphorylation of tubulin in Bal17 B-cells in response to receptor crosslinking was inhibited by pretreatment with piceatannol.
DISCUSSION
In lymphoid cells, the Src family kinases are localized to the particulate fraction where they are anchored by protein-protein and protein-membrane interactions mediated, in part, by postand co-translational acylations and the presence of SH3 domains (for review, see Ref. 45 ). Syk, which lacks both an SH3 domain and a consensus sequence for N-myristoylation, is distributed more evenly between the particulate and soluble fractions in B-cells (Fig. 1) . The distribution observed in B-cells is similar to that reported previously for peripheral blood lymphocytes (46) . Both Syk and Src family kinases are activated when transmembrane antigen receptors are aggregated by extracellular polyvalent ligands or antireceptor antibodies. The activated Src family kinases remain associated with membrane or cytoskeletal components present in the particulate fraction where they are presumably poised to phosphorylate physiologically relevant substrates also localized to these regions (e.g. components of the antigen receptor complex). Activated Syk, on the other hand, appears predominantly in the soluble fraction of B-cell lysates (Fig. 2) . Syk, activated in peripheral blood lymphocytes in response to interleukin-2, is also localized predominantly to the cytosolic fraction (46) . Thus, Syk may be positioned within the cell to interact with and phosphorylate a distinct subset of proteins distinguished from those of the Src family kinases, in part, by their subcellular location.
Biochemical and genetic evidence indicates that the BCRmediated activation of Syk proceeds via the association of its tandem, amino-terminal, SH2 domains with the tyrosine-phosphorylated ITAM motifs of Ig-␣ or Ig-␤ (21, 22, 47) . Thus, Syk would be expected to be recruited to the antigen receptor complex following its aggregation and phosphorylation. This recruitment of Syk to the receptor, however, does not measurably alter the overall subcellular distribution of the kinase between particulate and soluble fractions (Fig. 1) . Following the interaction of Syk with the phosphorylated ITAM or with dually phosphorylated peptides modeled on the ITAMs of Ig-␣ or Fc⑀RI-␥, Syk is activated as it becomes phosphorylated on tyrosine (21, 48) . In the intact B-cell, subcellular fractionation studies indicate that this tyrosine-phosphorylated Syk is almost exclusively confined to the soluble fraction (Fig. 2) . This is most easily seen in extracts prepared from human B-cells where enhanced tyrosine phosphorylation leads to a shift in the electrophoretic mobility of Syk to a slower migrating species (Fig. 1) . This slower migrating form of Syk is the major form that is immunoprecipitated with anti-phosphotyrosine antibodies (Fig. 2) . Immunoprecipitates of soluble, tyrosine-phosphorylated Syk do not contain the co-immunoprecipitated Ig-␣ that is visible in anti-Syk immune complexes isolated from the membrane fraction of activated B-cells (Fig. 3A) . These observations suggest a model whereby Syk interacts only transiently with the aggregated receptor and is released from the receptor when the kinase becomes phosphorylated on tyrosine. This phosphorylation could occur as a consequence of the actions of Src-family kinases or from Syk autophosphorylation. Increases in the intrinsic activity of Syk accompany this phosphorylation such that the activated Syk is also found predominantly in the soluble fraction (Figs. 1 and 3) .
Syk is also activated in B-cells treated with pervanadate, a potent protein tyrosine phosphatase inhibitor (Fig. 3) . In Bcells, vanadate, which also inhibits protein tyrosine phosphatases, induces the hyperphosphorylation of the Ig-␣ and Ig-␤ components of the BCR (49) and pervanadate likely functions in a similar fashion. This pervanadate-activated Syk does not remain associated with the phosphorylated antigen receptor complex and is found primarily in the soluble fraction (Fig. 3) . ZAP-70, a Syk homolog that is expressed predominantly in T-cells, also appears in a soluble, activated form when a Jurkat T-cell line that expresses both Syk and ZAP-70 is treated with pervanadate (Fig. 3) . This activation of ZAP-70 is blocked in J.CaM1 cells, 4 a Jurkat-derived cell line that lacks the functional Lck needed to phosphorylate components of the TCR/ CD3 complex (50) . Thus, ZAP-70 is likely released from the T-cell receptor following its activation and phosphorylation on tyrosine in a manner similar to that observed for Syk and the BCR.
Soluble, activated Syk would be poised to interact with and phosphorylate a subset of protein-tyrosine kinase target proteins present in the cytosol of activated cells. A key to the nature of one of these potential substrates was the observation that a 54-kDa protein co-immunoprecipitated with Syk and became phosphorylated on tyrosine in anti-Syk immune complexes. This protein was found in both anti-Syk immune complexes and among proteins adsorbed to an immobilized GSTSyk fusion protein (Fig. 4) . The 54-kDa protein was identified as tubulin by peptide mapping and by its loss from the cytosolic fraction of activated cells in which the polymerization of tubulin into microtubules was forced by pretreatment with Taxol (Fig. 5) .
Tubulin is an excellent in vitro substrate for Syk. Syk preferentially catalyzes the phosphorylation of the ␣-tubulin monomer on a single tyrosine residue localized to a region of the protein near the carboxyl terminus. This site lies within a carboxyl-terminal peptide that is released from ␣-tubulin following limited proteolytic digestion with subtilisin that has the sequence FSEAREDMAALEKDYEEVGVDSVEGEGEEEG-EEY (44) lian and chicken ␣-tubulin) (43, 51) . This peptide contains two tyrosine residues, one of which is located at the extreme carboxyl terminus and has been reported to be an in vitro site of phosphorylation catalyzed by the insulin receptor based on its rapid release in response to carboxypeptidase A (52). Treatment of Syk-phosphorylated tubulin with carboxypeptidase A, however, has little effect on its state of phosphorylation (Fig.  7B) , indicating that the tyrosine 20 residues upstream from the carboxyl terminus, Tyr 432 , rather than the carboxyl-terminal tyrosine, is the major site of phosphorylation. Other proteintyrosine kinases have been reported to phosphorylate tubulin, but the pattern of phosphorylation generally differs from that observed with Syk. For example, Src phosphorylates ␣-and ␤-tubulin with nearly equal efficiency in vitro (53) and in nerve growth cone membranes (54) , while the epidermal growth factor receptor preferentially phosphorylates ␤-tubulin (53).
In our hands, Syk demonstrates a highly restricted substrate specificity in vitro (55) . The site of Syk phosphorylation on ␣-tubulin is similar in sequence to the sites of phosphorylation previously identified on the erythrocyte anion transport channel (band 3) (56) and glycogen synthase (57) . An alignment of the phosphorylation sites identified on these three substrates indicate a strong preference for acidic amino acid residues located both proximal and distal to the site of tyrosine phosphorylation: ␣-tubulin, Met-Ala-Ala-Leu-Glu-Lys-Asp-Tyr-GluGlu-Val-Gly; band 3, Met-Glu-Glu-Leu-Asn-Asp-Asp-Tyr-GluAsp-Asp-Met-; glycogen synthase, Pro-Glu-Glu-Asp-Gly-GluArg-Tyr-Glu-Asp-Glu-Glu-. ␤-Tubulin, which also contains a conserved tyrosine residue in an analogous position (43) , lacks the surrounding acidic residues that are important for substrate recognition by Syk and is not readily phosphorylated by Syk in vitro (Fig. 7) . Sites of Syk phosphorylation that have been sequenced for histone H2B (58) and myelin basic protein (41) do not fit this general motif. However, myelin basic protein is a comparatively poor substrate for Syk (Fig. 6 ) and is phosphorylated at a rate much slower than that observed for the phosphorylation of band 3 or ␣-tubulin.
Tubulin is also phosphorylated on tyrosine in intact B-cells following aggregation of the BCR (Fig. 8) . This phosphorylation occurs under conditions in which Syk is activated and occurs primarily on the ␣-subunit. Preferential phosphorylation of ␣-tubulin is consistent with the demonstrated substrate specificity of the kinase in vitro (Fig. 7) . The preincubation of B-cells with piceatannol at concentrations in which the activation of Syk is preferentially inhibited blocks receptor-mediated phosphorylation of tubulin, suggesting that Syk is the kinase primarily responsible for the tyrosine phosphorylation of tubulin following receptor aggregation. The observation that tubulin is phosphorylated in activated lymphoid cells is similar to that reported previously by Ley et al. (59) who found that ␣-tubulin is tyrosine-phosphorylated in human T lymphocytes in response to engagement of the T-cell antigen receptor. The phosphorylated ␣-tubulin was restricted to the 45% of tubulin that is not polymerized in Jurkat T-cells (59) . TCR engagement leads to the activation of ZAP-70, a Syk homolog found in T-cells that has a substrate specificity similar to that of Syk. When Jurkat T-cells are treated with pervanadate, activated ZAP-70 appears in the soluble fraction (Fig. 3) where the unpolymerized ␣-tubulin would be expected to be located. Thus, ZAP-70 would be a good candidate for the T-cell ␣-tubulin kinase.
Determinations of the effect that tyrosine-phosphorylation has on the properties of tubulin and the role that this plays in B-cell function must await further experimentation. Tubulin phosphorylated on the carboxyl-terminal tyrosine by the insulin receptor fails to polymerize into microtubules (52) . Similarly, ␣-and ␤-tubulin phosphorylated near the carboxyl terminus by a Ca 2ϩ /calmodulin-dependent protein kinase fails to polymerize (60) . An inhibitory effect of phosphorylation on the incorporation of tubulin into microtubules is also consistent with the observation that ␣-tubulin, phosphorylated in response to ligation of the TCR, is found exclusively in the cytosolic fractions of Jurkat T-cells (59) . Thus, tyrosine phosphorylation may play a role in altering the microtubule/tubulin monomer equilibrium by lowering the pool of tubulin monomers available for polymerization. The acidic carboxyl-terminal region of tubulin contains the sites of interaction with the microtubule-associated proteins (MAPs) that regulate microtubule assembly and function (61, 62) . Through the use of synthetic peptides, the site of interaction of MAP2 and tau with ␣-tubulin has been narrowed to a 12 amino acid region, KDYEEVGVDSVE, that encompasses Tyr 432 (61) . Antibodies prepared against a peptide corresponding in sequence to this region block MAP-induced microtubule assembly and depolymerize preformed microtubules (62) . Thus, phosphorylation in this region of ␣-tubulin might reasonably be expected to alter its association with one or more MAPs. The binding of the acidic amino terminus of erythrocyte band 3 to glycolytic enzymes is inhibited by tyrosine phosphorylation (56). By analogy to band 3, the phosphorylation of ␣-tubulin may likewise block its ability to interact with MAPs. Alternatively, tyrosine-phosphorylated tubulin could serve as a binding site for signaling molecules that possess SH2 domains and could serve a role in mediating their redistribution within the cell following receptor aggregation. Experiments to explore these possibilities are currently under way.
